Use of the carbon dioxide laser to manage cutaneous metastases from malignant melanoma

被引:39
作者
Hill, S
Thomas, M
机构
[1] ROYAL MARSDEN HOSP,DEPT SURG,LONDON SW3 6JJ,ENGLAND
[2] CHELSEA & WESTMINSTER HOSP,DEPT SURG,LONDON,ENGLAND
关键词
D O I
10.1002/bjs.1800830425
中图分类号
R61 [外科手术学];
学科分类号
摘要
Between October 1988 and November 1994, 100 patients with cutaneous metastases from malignant melanoma were treated by carbon dioxide laser ablation under local or general anaesthesia as appropriate. There were minimal postoperative complications and most wounds healed within 6 weeks, A total of 34 of the 53 patients in this series with stage IIIa disease were controlled with four or fewer laser ablations during the first year from presentation. This technique provides a simple effective alternative to hyperthermic isolated limb perfusion with melphalan. Patients with disease not controlled by laser can be considered for isolated limb perfusion.
引用
收藏
页码:509 / 512
页数:4
相关论文
共 21 条
[1]   ISOLATED LIMB PERFUSION WITH MELPHALAN IN THE TREATMENT OF MALIGNANT-MELANOMA [J].
BULMAN, AS ;
JAMIESON, CW .
BRITISH JOURNAL OF SURGERY, 1980, 67 (09) :660-662
[2]  
CAVALIERE R, 1994, MELANOMA RES, V4, P5
[3]   CHEMOTHERAPY OF CANCER - REGIONAL PERFUSION UTILIZING AN EXTRACORPOREAL CIRCUIT [J].
CREECH, O ;
KREMENTZ, ET ;
RYAN, RF ;
WINBLAD, JN .
ANNALS OF SURGERY, 1958, 148 (04) :616-632
[4]   ISOLATION PERFUSION FOR MALIGNANT-MELANOMA OF THE EXTREMITY - A REVIEW [J].
CUMBERLIN, R ;
DEMOSS, E ;
LASSUS, M ;
FRIEDMAN, M .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (07) :1022-1031
[5]  
DIFILIPPO F, 1989, CANCER, V63, P2551
[6]  
GHUSSEN F, 1984, ANN SURG, V200, P764
[7]  
HILL GJ, 1988, SKIN CANC RECOGNITIO
[8]  
Hill S, 1993, Eur J Surg Oncol, V19, P173
[9]   LOW-DOSE TUMOR-NECROSIS-FACTOR-ALPHA AND MELPHALAN IN HYPERTHERMIC ISOLATED LIMB PERFUSION [J].
HILL, S ;
FAWCETT, WJ ;
SHELDON, J ;
SONI, N ;
WILLIAMS, T ;
THOMAS, JM .
BRITISH JOURNAL OF SURGERY, 1993, 80 (08) :995-997
[10]  
Krementz E T, 1979, World J Surg, V3, P289